Curated News
By: NewsRamp Editorial Staff
September 25, 2026
SS Innovations' SSi Mantra Hits 50 Daily Procedures, Eyes Global Expansion
TLDR
- SS Innovations' SSi Mantra robotic system with 224 installations and 143% procedure growth offers investors a strong edge in surgical robotics.
- SS Innovations expands its SSi Mantra robotic system through installations, regulatory approvals, and telesurgery development, with revenue up 39% to $13.9 million.
- SS Innovations makes robotic surgery affordable and accessible, improving global healthcare by expanding advanced surgical options to more people.
- SS Innovations' SSi Mantra system enabled over 50 robotic procedures in one day in India and is now installed in 12 countries.
Impact - Why it Matters
This news matters because it highlights the growing adoption of cost-effective robotic surgery solutions, which could democratize access to advanced surgical care worldwide. As SS Innovations expands into Europe and the U.S., it may intensify competition in the surgical robotics market, potentially driving down costs and improving patient outcomes. The company's focus on telesurgery and training also signals a future where remote surgeries become more common, benefiting patients in underserved regions.
Summary
SS Innovations International (NASDAQ: SSII) is making significant strides in the surgical robotics market, leveraging strong momentum in India to fuel international expansion. The company’s SSi Mantra system recently achieved a milestone of over 50 robotic procedures in a single day at Mohak Bariatrics and Robotics in Indore. With 224 systems installed across 12 countries and a 143% year-over-year increase in robotic procedures during Q2 2026, SS Innovations is demonstrating robust adoption. Quarterly revenue climbed 39% to $13.9 million, with system sales up 41% to $12.4 million, and 30 new installations during the quarter.
While India remains the primary commercial market, the company is actively pursuing regulatory approvals in Europe and the United States, targeting CE marking by the end of 2026 and FDA 510(k) review by the end of Q1 2027. SS Innovations is also developing telesurgery capabilities and expanding surgeon training to drive utilization and establish its platform in new markets. The company’s product suite includes the SSi Mantra surgical robotic system and SSi Mudra surgical instruments, designed to make robotic surgery affordable and accessible globally. For more details, visit https://ibn.fm/6FPBS.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations' SSi Mantra Hits 50 Daily Procedures, Eyes Global Expansion
